Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study

AIMS/HYPOTHESIS: Insulin degludec (Des(B30)LysB29(γ-Glu Nε-hexadecandioyl) human insulin; IDeg) is a new basal insulin with an ultra-long flat action profile. The acute physiological responses to hypoglycaemia with IDeg and insulin glargine (A21Gly,B31Arg,B32Arg human insulin; IGlar) were compared....

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Koehler, Gerd, Heller, Simon, Korsatko, Stefan, Roepstorff, Carsten, Rasmussen, Søren, Haahr, Hanne, Pieber, Thomas R.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Berlin Heidelberg 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3855490/
https://ncbi.nlm.nih.gov/pubmed/24057153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-013-3056-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky